Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Ariad Pharma Discontinues Phase III Trial of Ponatinib (Iclusig) in Leukemia Patients

 

Ariad Pharma Discontinues Phase III Trial of Ponatinib (Iclusig) in Leukemia Patients

2013-10-20 13:07:47| Biotech - Topix.net

Ariad Pharmaceuticals, Inc. has announced that it is discontinuing the phase III EPIC trial of ponatinib in patients with newly diagnosed chronic myeloid leukemia .

Tags: iii trial phase patients

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

18.05 Unpaid carers being forced to repay 250m to DWP 18.05 Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories 18.05 Eastern North Pacific Tropical Weather Outlook 18.05 Atlantic Tropical Weather Outlook 18.05 Eastern North Pacific Tropical Weather Outlook 18.05 Atlantic Tropical Weather Outlook 17.05 House Republicans release farm bill draft 17.05 House Republicans release farm bill draft More »